Quadrant wins EUA for COVID-19 saliva test

2019 05 28 19 27 1157 Approved Stamp 400

Quadrant Biosciences has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Clarifi COVID-19 test kit.

Developed in partnership with State University of New York (SUNY) Upstate Medical University, the saliva swab test determines the presence or absence of SARS-CoV-2 viral RNA, according to the company. It contains a saliva collection swab and the reagents needed to perform the analysis. Clarifi is available now for clinical laboratories serving patients through physicians' offices, urgent care clinics, and hospitals, Quadrant said.

Page 1 of 40
Next Page